# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105220
Filing Date
2025-08-07
Accepted
2025-08-07 17:01:11
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcab-20250630.htm iXBRL | 10-Q | 2242980
2 | EX-10.1 | bcab-ex10_1.htm | EX-10.1 | 984160
3 | EX-31.1 | bcab-ex31_1.htm | EX-31.1 | 17275
4 | EX-31.2 | bcab-ex31_2.htm | EX-31.2 | 17198
5 | EX-32.1 | bcab-ex32_1.htm | EX-32.1 | 16102
6 | GRAPHIC | img265655234_0.jpg | GRAPHIC | 29965
| Complete submission text file | 0000950170-25-105220.txt |  | 9384619

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | bcab-20250630.xsd | EX-101.SCH | 1074131
69 | EXTRACTED XBRL INSTANCE DOCUMENT | bcab-20250630_htm.xml | XML | 1449753

Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39787 | Film No.: 251195160
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)